Cardiovascular disease in women

Area of Science:

• Cardiology
• Preventive Medicine
• Women's Health

Background:

• Cardiovascular disease (CVD) is the leading cause of death in American women.
• Atherosclerotic diseases, including myocardial infarction and stroke, significantly impact women's health.
• Women develop CVD approximately 10 years later than men, with similar numbers of myocardial infarctions.

Purpose of the Study:

• To highlight the importance of cholesterol levels in cardiovascular disease risk for women.
• To identify key lipid parameters associated with coronary heart disease (CHD) risk in women.
• To provide target lipid levels for reducing CHD risk.

Main Methods:

• Analysis of epidemiological data on cardiovascular disease in women.
• Review of established risk factors for coronary heart disease.
• Examination of clinical trial outcomes related to cholesterol reduction therapies.

Main Results:

• Total serum cholesterol is a primary risk indicator; a 1% increase correlates with a 2% increase in CHD incidence.
• High low-density lipoprotein (LDL) is a risk factor for both sexes; high triglycerides are a risk factor specifically for women.
• High-density lipoprotein (HDL) inversely correlates with CHD risk.
• Target total cholesterol levels should be lowered to 200 mg/dl.
• A total cholesterol/HDL ratio ≥ 4.5 or LDL > 150 mg/dl indicates high CHD risk.

Conclusions:

• Aggressive lowering of serum cholesterol levels is essential for reducing cardiovascular disease and coronary heart disease incidence in women.
• Monitoring lipid profiles, including total cholesterol, LDL, HDL, and triglycerides, is critical for assessing and managing cardiovascular risk in women.
• Clinical interventions targeting cholesterol reduction demonstrate a consistent 2% decrease in CHD incidence for every 1% reduction in total cholesterol.